seed
Stage
1
Investors
About
A biotechnology company developing an in vivo CRISPR screening platform to map disease biology and accelerate drug discovery, with an initial focus on oncology.
Explore Vevo Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.